EXPRES2ION - Trademark Details
Status: 700 - Registered
Serial Number
79159531
Registration Number
4893901
Word Mark
EXPRES2ION
Status
700 - Registered
Status Date
2016-02-02
Filing Date
2014-03-14
Registration Number
4893901
Registration Date
2016-02-02
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2015-11-17
Attorney Name
Law Office Assigned Location Code
M40
Employee Name
DESAI, BRIN ANDERSON
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the term "EXPRES2ION" where the "2" is displayed in superscript.
Goods and Services
Biological reagents for scientific and research purposes; biological and chemical preparations for use in biotechnology, namely, oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and reagents for use in genetic and proteomics research; chemicals and polymers other than for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; chemicals, namely, solid phases other than for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; reagents containing ligands, effector molecules and antibodies for scientific and medical research use; antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; chemicals, biochemicals and reagents for use in industry, science and research; chemical compositions for scientific and industrial use in the preparation of culture media; media for cell/tissue cultures, cell/tissue culture growth supplements, reagents and buffers for use in cell/tissue cultures, transfection reagents, cryopreservation reagents other than for medical or veterinary purposes; reagents containing proteins, ligands, effector molecules and antibodies for scientific or medical research use; biological and biochemical preparations for scientific or medical research use, namely, oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and reagents for use in genetic and proteomics research; reagents and kits consisting of chemicals, biochemicals and reagents, all for scientific or research use; kits for scientific and research use consisting primarily of one or more of the following: proteins, nucleic acids, hormones, purification supports, resins, cells, gels, buffers, stains and associated reagents for the expression, amplification, purification and analysis of biological samples; protein and kits consisting primarily of oligonucleotides, peptide substrates, assays and reagents for use in genetic and proteomics research and for research purposes in biochemical laboratories; cell lines for use in scientific, laboratory, diagnostic and medical research; biological and chemical preparations for use in biotechnology, namely, oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and reagents for use in genetic and proteomics research; chemical and biological products for use in medical science, namely, oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and reagents for use in genetic and proteomics research; microbiological and tissue culture media, animal blood and serum, and reagents and kits consisting of chemicals, biochemicals, and reagents, all for scientific research; chemicals used for medical research purposes, namely, reagents containing proteins, ligands, effector molecules, and antibodies for medical research use; insect cells, insect cell culture media, and cell culture reagents all for medical laboratory use; reagents and kits consisting of chemicals, biochemicals, and reagents, all for medical diagnostic laboratory use
Goods and Services
Chemicals and polymers for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; chemicals, namely, solid phases for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; insect cells, insect cell culture media and cell culture reagents all for medical use; pharmaceutical preparations and substances and therapeutic pharmaceuticals for use in the diagnosis, prophylaxis and treatment of cancers, infectious diseases, autoimmune diseases, ophthalmological diseases, metabolic diseases, respiratory diseases, cardiovascular diseases, genetic diseases, and central nervous system conditions; preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body; biological and biochemical preparations for medical purposes for use in the diagnosis, prophylaxis and treatment of cancers, infectious diseases, autoimmune diseases, ophthalmological diseases, metabolic diseases, respiratory diseases, cardiovascular diseases, genetic diseases, and central nervous system conditions; microbiological and tissue culture media, animal blood and serum, and reagents and kits consisting of chemicals, biochemicals, and reagents, all for medical use; chemicals used for medical purposes, namely, reagents, proteins, cells, reagents containing proteins, ligands, effector molecules, and antibodies for medical use
Goods and Services
Medical and scientific research; research and consultation services in the fields of pharmaceuticals, vaccines, medicine, biological sciences, immunotherapy, and medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; scientific medical laboratory services; research and development for vaccines and new immunotherapy products for others; scientific and technological services, namely, research and design in the fields of medical diagnostics, vaccines, and pharmaceuticals; industrial analysis and research services in the fields of medical diagnostics, vaccines, and pharmaceuticals; research and development services all relating to science; research and development services all relating to industry in the fields of medical diagnostics, vaccines, and pharmaceuticals; research and development services all relating to science; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical research or in biochemical research; laboratory research services in the field of gene cloning, gene expression, electrophoresis, protein purification and analysis, and protein interaction detection; providing research data and other molecular biology information for molecular biology reagents and kits in the fields of science and research; scientific research and development; medical and scientific research in the field of molecular biology; biological research; biological cloning services; providing information on the subject of scientific research in the fields of biochemistry and biotechnology; scientific research in the fields of genetics and genetic engineering; biochemical research and development; chemical, biochemical, biological and bacteriological research and analysis; providing reagent sample testing and diagnostic services for others in the field of science and research related thereto; DNA screening for scientific purposes; genetic mapping for scientific purposes; genetic testing for scientific research purposes; providing scientific information via a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; providing information in the field of molecular biology for scientific research purposes, also via on line searchable databases; providing scientific data in protein purification and analysis, and protein interaction detection; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers with prophylactic and/or therapeutic purposes; technical research and consultation services in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific medical laboratory testing and diagnostic services for scientific research purposes; scientific research, namely, developing customized insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract scientific laboratory services and related consulting focused primarily on protein expressions, cell line development, and biotechnology upstream production process development
Pseudo Mark
EXPRESSION; EXPRES TWO ION
Pseudo Mark
EXPRESSION; EXPRES TWO ION
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2015-02-06
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-02-06
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2015-02-06
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Paula Jill Krasny
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1233716
International Registration Date
2014-03-14
International Publication Date
2015-02-05
International Renewal Date
2024-03-14
Auto Protection Date
2016-08-05
International Status
001 - Request for extension of protection established
International Status Date
2015-02-05
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2015-02-05 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2015-02-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2015-02-06 | ASSIGNED TO EXAMINER |
2015-02-10 | APPLICATION FILING RECEIPT MAILED |
2015-02-23 | NON-FINAL ACTION WRITTEN |
2015-02-23 | NON-FINAL ACTION WRITTEN |
2015-02-24 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2015-02-24 | REFUSAL PROCESSED BY MPU |
2015-02-24 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2015-03-13 | REFUSAL PROCESSED BY IB |
2015-06-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2015-06-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2015-06-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2015-06-12 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2015-06-12 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2015-07-07 | FINAL REFUSAL WRITTEN |
2015-07-07 | FINAL REFUSAL E-MAILED |
2015-07-07 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2015-09-08 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2015-09-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2015-09-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2015-09-10 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2015-10-08 | ASSIGNED TO LIE |
2015-10-14 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2015-10-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-11-04 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2015-11-04 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2015-11-17 | PUBLISHED FOR OPPOSITION |
2015-11-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-11-20 | NOTIFICATION PROCESSED BY IB |
2016-02-02 | REGISTERED-PRINCIPAL REGISTER |
2016-05-02 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2016-05-04 | FINAL DISPOSITION PROCESSED |
2016-05-04 | FINAL DISPOSITION NOTICE SENT TO IB |
2016-07-08 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2016-09-15 | NEW REPRESENTATIVE AT IB RECEIVED |
2018-12-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2018-12-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-04-16 | NEW REPRESENTATIVE AT IB RECEIVED |
2021-02-02 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |